Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.
Lefevre, P A
Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol. [electronic resource] - Mutagenesis Jan 1997 - 45-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0267-8357
10.1093/mutage/12.1.45 doi
Animals
Animals, Genetically Modified
Bacterial Proteins--drug effects
Benzothiazoles
Carcinogens--toxicity
Diet
Escherichia coli Proteins
Lac Repressors
Liver--drug effects
Male
Mutagenesis
Mutagenicity Tests
Mutation
Rats
Rats, Inbred F344
Repressor Proteins--drug effects
Riboflavin--pharmacology
Sensitivity and Specificity
Thiazoles--toxicity
Transgenes
p-Dimethylaminoazobenzene--analogs & derivatives
Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol. [electronic resource] - Mutagenesis Jan 1997 - 45-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0267-8357
10.1093/mutage/12.1.45 doi
Animals
Animals, Genetically Modified
Bacterial Proteins--drug effects
Benzothiazoles
Carcinogens--toxicity
Diet
Escherichia coli Proteins
Lac Repressors
Liver--drug effects
Male
Mutagenesis
Mutagenicity Tests
Mutation
Rats
Rats, Inbred F344
Repressor Proteins--drug effects
Riboflavin--pharmacology
Sensitivity and Specificity
Thiazoles--toxicity
Transgenes
p-Dimethylaminoazobenzene--analogs & derivatives